SEPTInvestingStart Free

VRAX 424B3: Secondary offering

Virax Biolabs Group Ltd

Filed with the SEC on · accession 0001193125-26-386697

VRAX filed a 424B3 (prospectus (offering)) with the SEC on Sep 10, 2026. Virax Biolabs Group Ltd filed a prospectus for the resale of up to 1,682,360 ordinary shares by selling shareholders, primarily upon exercise of warrants issued in connection with an inducement letter and placement agent agreement. The stock moved +4.4% by the first close after the filing.

Summary of the filing

Virax Biolabs Group Ltd filed a prospectus for the resale of up to 1,682,360 ordinary shares by selling shareholders, primarily upon exercise of warrants issued in connection with an inducement letter and placement agent agreement. The company will not receive proceeds from the resale but may receive proceeds from cash exercise of the warrants.

For details, click here →How to read a 424B3 →

Key details

Maximum shares offered for resaleshares 1.7M
Exercise price of New Warrants$6
Exercise price of Placement Agent Warrants$8
Stock price on September 2, 2026$3
IssuerVirax Biolabs Group Ltd
Placement agentH.C. Wainwright & Co., LLC

How VRAX stock reacted

Close before

$2.73

Sep 9, 2026

First close after

+4.40%

$2.85

5 trading days

-8.79%

$2.49

Since filing

-77.56%

$0.61

✦ Ask GOAX AI about this filing — what it means for VRAX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VRAX?

Click here

Frequently asked questions

What did VRAX file with the SEC on Sep 10, 2026?

VRAX filed a 424B3 (Secondary offering). Virax Biolabs Group Ltd filed a prospectus for the resale of up to 1,682,360 ordinary shares by selling shareholders, primarily upon exercise of warrants issued in connection with an inducement letter and placement agent agreement. The company will not receive proceeds from the resale but may receive proceeds from cash exercise of the warrants.

What does a secondary offering mean for VRAX stock?

New shares dilute existing holders and are often sold at a discount to the market price.

How do I read a 424B3?

The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.

How did VRAX stock react to this filing?

VRAX closed at $2.73 before the filing and $2.85 on Sep 10, 2026 (+4.40%). Five trading days later: $2.49 (-8.79%).

Other VRAX SEC filings

Get alerts when VRAX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VRAX overviewVRAX analysisVRAX newsLatest SEC filings